Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 3029

1.

Serum lipids and glucose control: the SEARCH for Diabetes in Youth study.

Petitti DB, Imperatore G, Palla SL, Daniels SR, Dolan LM, Kershnar AK, Marcovina S, Pettitt DJ, Pihoker C; SEARCH for Diabetes in Youth Study Group.

Arch Pediatr Adolesc Med. 2007 Feb;161(2):159-65.

PMID:
17283301
2.

Prevalence and phenotypic distribution of dyslipidemia in type 1 diabetes mellitus: effect of glycemic control.

Pérez A, Wägner AM, Carreras G, Giménez G, Sánchez-Quesada JL, Rigla M, Gómez-Gerique JA, Pou JM, de Leiva A.

Arch Intern Med. 2000 Oct 9;160(18):2756-62.

PMID:
11025785
3.

Lipid abnormalities are prevalent in youth with type 1 and type 2 diabetes: the SEARCH for Diabetes in Youth Study.

Kershnar AK, Daniels SR, Imperatore G, Palla SL, Petitti DB, Pettitt DJ, Marcovina S, Dolan LM, Hamman RF, Liese AD, Pihoker C, Rodriguez BL.

J Pediatr. 2006 Sep;149(3):314-9.

PMID:
16939739
4.

The impact of outpatient diabetes management on serum lipids in urban African-Americans with type 2 diabetes.

Erdman DM, Cook CB, Greenlund KJ, Giles WH, El-Kebbi I, Ryan GJ, Gallina DL, Ziemer DC, Dunbar VG, Phillips LS.

Diabetes Care. 2002 Jan;25(1):9-15.

PMID:
11772894
5.

Ethnicity and glycaemic control are major determinants of diabetic dyslipidaemia in Malaysia.

Ismail IS, Nazaimoon W, Mohamad W, Letchuman R, Singaraveloo M, Hew FL, Shuguna C, Khalid BA.

Diabet Med. 2001 Jun;18(6):501-8.

PMID:
11472471
7.

Clinical significance of HbA1c as a marker of circulating lipids in male and female type 2 diabetic patients.

Ahmad Khan H.

Acta Diabetol. 2007 Dec;44(4):193-200. Epub 2007 Sep 1.

PMID:
17786383
8.
9.

Lipoprotein lipids in older people. Results from the Cardiovascular Health Study. The CHS Collaborative Research Group.

Ettinger WH, Wahl PW, Kuller LH, Bush TL, Tracy RP, Manolio TA, Borhani NO, Wong ND, O'Leary DH.

Circulation. 1992 Sep;86(3):858-69.

PMID:
1516198
10.

Relationship between ethnicity and glycemic control, lipid profiles, and blood pressure during the first 9 years of type 2 diabetes: U.K. Prospective Diabetes Study (UKPDS 55).

Davis TM, Cull CA, Holman RR; U.K. Prospective Diabetes Study (UKPDS) Group.

Diabetes Care. 2001 Jul;24(7):1167-74.

PMID:
11423497
11.

The impact of pioglitazone on glycemic control and atherogenic dyslipidemia in patients with type 2 diabetes mellitus.

Rosenblatt S, Miskin B, Glazer NB, Prince MJ, Robertson KE; Pioglitazone 026 Study Group.

Coron Artery Dis. 2001 Aug;12(5):413-23.

PMID:
11491207
12.

Factors associated with plasma lipids and lipoproteins in type 1 diabetes mellitus: the EURODIAB IDDM Complications Study.

Idzior-Walus B, Mattock MB, Solnica B, Stevens L, Fuller JH; EURODIAB IDDM Complications Study Group.

Diabet Med. 2001 Oct;18(10):786-96.

PMID:
11678968
13.

The long-term effects of rosiglitazone on serum lipid concentrations and body weight.

Shim WS, Do MY, Kim SK, Kim HJ, Hur KY, Kang ES, Ahn CW, Lim SK, Lee HC, Cha BS.

Clin Endocrinol (Oxf). 2006 Oct;65(4):453-9.

PMID:
16984237
14.

Influence of food intake, age, gender, HbA1c, and BMI levels on plasma cholesterol in 29,979 children and adolescents with type 1 diabetes--reference data from the German diabetes documentation and quality management system (DPV).

Schwab KO, Doerfer J, Naeke A, Rohrer T, Wiemann D, Marg W, Hofer SE, Holl RW; German/Austrian Pediatric DPV Initiative.

Pediatr Diabetes. 2009 May;10(3):184-92. doi: 10.1111/j.1399-5448.2008.00469.x. Epub 2008 Oct 10.

PMID:
19175904
15.

Lipid peroxidation and antioxidant enzyme levels in type 2 diabetics with microvascular complications.

Kesavulu MM, Giri R, Kameswara Rao B, Apparao C.

Diabetes Metab. 2000 Nov;26(5):387-92.

16.

Biological variation of serum lipids and lipoproteins in patients with clinically well controlled non insulin dependent diabetes mellitus.

Yildirimkaya M, Bil Gi C, Ozata M, Nazaroğlu NK, Gündoğan MA, Kutluay T, Karaca L.

Endocr J. 1996 Jun;43(3):345-51.

17.

Associations of serum lipids with metabolic control and diet in young subjects with insulin-dependent diabetes mellitus in Finland.

Virtanen SM, Räsänen L, Virtanen M, Sippola H, Rilva A, Kaprio EA, Mäenpää J, Akerblom HK.

Eur J Clin Nutr. 1993 Feb;47(2):141-9.

PMID:
8436092
18.

Effect of intensive glycemic control on fibrinogen, lipids, and lipoproteins: Veterans Affairs Cooperative Study in Type II Diabetes Mellitus.

Emanuele N, Azad N, Abraira C, Henderson W, Colwell J, Levin S, Nuttall F, Comstock J, Sawin C, Silbert C, Marcovina S, Lee HS.

Arch Intern Med. 1998 Dec 7-21;158(22):2485-90.

PMID:
9855387
19.

Long-term intraindividual variability of serum lipids in patients with type I and type II diabetes.

Tsalamandris C, Panagiotopoulos S, Allen TJ, Waldrip L, Van Gaal B, Goodall I, Jerums G.

J Diabetes Complications. 1998 Jul-Aug;12(4):208-14.

PMID:
9647339
20.

Colesevelam hydrochloride therapy in patients with type 2 diabetes mellitus treated with metformin: glucose and lipid effects.

Bays HE, Goldberg RB, Truitt KE, Jones MR.

Arch Intern Med. 2008 Oct 13;168(18):1975-83. doi: 10.1001/archinte.168.18.1975.

PMID:
18852398
Items per page

Supplemental Content

Write to the Help Desk